We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Pressurized Topical Oxygen Aids Diabetic Foot Ulcers Heal

By HospiMedica International staff writers
Posted on 13 Nov 2019
Print article
Image: Cyclical pressurized TWO2 therapy cures recalcitrant ulcers (Photo courtesy of AOTI)
Image: Cyclical pressurized TWO2 therapy cures recalcitrant ulcers (Photo courtesy of AOTI)
Topical wound oxygen (TWO2) therapy can lead to a fourfold increase in chronic diabetic foot ulcer (DFU) healing, according to a new study.

Researchers at Northwick Park Hospital (London, United Kingdom), Midwestern University (Glendale, AZ, USA), Montpellier University Hospital (France), and other institutions conducted a study involving 220 patients to assess the efficacy of multimodality cyclical pressure TWO2 home care therapy in healing refractory DFUs that failed to heal with standard of care alone. Patients with diabetes and chronic DFUs were randomized to either active TWO2 therapy or to sham control, which was operatively identical, apart from the delivery of oxygen.

After training, the patients treated themselves at home for 90 minutes, five times per week for 12 weeks or until the wound healed, with dressing changes performed by the patient themselves or by caregivers. The patients also visited their local study center every week for wound assessment, debridement, and photography, during which diary cards recording therapy delivery and daily off-loading compliance were verified. The primary outcome was 100% healing at 12 weeks.

The results showed that active TWO2 was superior to sham, with a closure rate of 41.7% at 12 weeks, as compared to 13.5% with standard care. After treatment was completed, the patients were followed for a maximum of 38 weeks, at which point wound closure assessment and quality of life questionnaires were administered. At that time, only one (6.7%) of 15 healed ulcers in the active arm recurred at 12 months, compared to two (40%) of five healed ulcers in the sham arm. Two patients in the active arm and three in the sham arm underwent index limb amputations. The study was published on October 16, 2019 in Diabetes Care.

“TWO2 should be made available for all chronic foot ulcers that are stalled and are not healing with standard care,” said lead author Robert Frykberg, DPM, MPH, of Midwestern University. “You would never use an advanced therapy such as this on an acute wound initially, unless that wound had already failed a number of other treatments. Generally, you try well-accepted standard wound care for four weeks or so before you start considering advanced therapies, which is what this is.”

Diabetes patients often suffer from nerve and circulation problems in the feet, which reduce their perception of pain. The nerve pathways that ensure that weight is automatically transferred from one foot to the other during prolonged standing are disrupted, and as a result, diabetics do not notice that their toes, heels, or the balls of their feet are too heavily loaded. The foot receives no relief, and DFUs, pressure sores, and infections may go unnoticed. Serious cases may even lead to amputation.

Related Links:
Northwick Park Hospital
Midwestern University
Montpellier University Hospital


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Anesthesia Workstation
X40

Print article

Channels

Surgical Techniques

view channel
Image: The implantable ventricular assist device can support a child’s failing heart (Photo courtesy of Jarvik Heart, Inc.)

Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant

Implantable ventricular assist devices, available for adults for over 40 years, fit inside the chest and are generally safer and easier to use than external devices. These devices enable patients to live... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more